Enfusion

Enfusion Operating Cash Flow

Delisted

The Operating Cash Flow of Enfusion (ENFN) as of Nov 7, 2026 is 34.68 M USD. In the previous year, Operating Cash Flow was 25.63 M USD — a change of 35.30% (higher).

Operating Cash Flow

34.68 MUSD

YoY

35.30%

Last updated:

Operating Cash Flow of Enfusion is 2024 34.68 M USD. Operating Cash Flow of Enfusion was 2023 25.63 M USD. It decreases by 35.30% higher compared to the previous year.

The Enfusion Operating Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Cash Flow
Date
Operating Cash Flow
Jan 1, 2019
12.31 M USD
Jan 1, 2020
1.67 M USD
Jan 1, 2021
-318,000.00 USD
Jan 1, 2022
14.16 M USD
Jan 1, 2023
25.63 M USD
Jan 1, 2024
34.68 M USD
The Enfusion Operating Cash Flow history
YEAROperating Cash FlowYoY
34.68 MUSD+35.30%
25.63 MUSD+81.08%
14.16 MUSD-4,551.57%
-318,000.00USD-119.10%
1.67 MUSD-86.47%
12.31 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Enfusion Stock analysis

What does Enfusion do? Enfusion Inc. generates revenue through cloud-native multi-tenant software solutions tailored for alternative and institutional investment managers. Its core products include the Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System, and Enfusion Analytics System, which collectively enable real-time investment decision-making. The company serves investment managers who require integrated systems for the full investment lifecycle, with PMS constructing and rebalancing portfolios while generating a real-time investment book of record, and OEMS facilitating electronic trade order communication for portfolio managers, traders, compliance teams, and analysts. The company's solution integrates technology-powered managed services to drive insights and control over investment operations. Enfusion's end-to-end functionality supports the entire investment process, from portfolio construction to trade execution, with PMS and OEMS operating in tandem to provide a seamless workflow. Investment managers across alternative and institutional segments purchase these integrated systems to enhance operational efficiency and decision-making capabilities. Enfusion's software is designed to serve the full investment lifecycle, with its systems integrated to provide a unified platform for portfolio management, order execution, accounting, and analytics. The company's revenue model is based on delivering these comprehensive solutions to investment managers who rely on real-time data and integrated workflows to manage their operations effectively. Enfusion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enfusion stock

Operating Cash Flow of Enfusion is 34.68 M USD in 2024.

Operating Cash Flow of Enfusion changed from 25.63 M USD to 34.68 M USD, representing a 35.30% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Enfusion since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow measures the cash generated from core business operations. It is a pure measure of a company's ability to generate cash.

Operating Cash Flow's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Operating Cash Flow's Enfusion historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Enfusion

All Key Metrics — Enfusion